Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and the United States of America (USA). The purpose of this
study is to test whether insulin detemir is a safe and at least as effective alternative to
insulin glargine for the control of blood glucose in basal/bolus therapy in patients with
type 2 diabetes.